MediPharm Labs Corp. (MEDIF)

0.0572 -0.0005 (-0.87%) At close: 02:09PM EDT

MediPharm Labs Corp.

151 John Street
Barrie, ON L4N 2L1
Canada
705-719-7425
https://www.medipharmlabs.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 166

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David A. Pidduck	CEO & Director	498.8k	N/A	N/A
Mr. Keith Strachan	Co-Founder & President	466.92k	N/A	N/A
Mr. Greg Hunter	Chief Financial Officer	570.48k	N/A	N/A
Mr. Patrick McCutcheon	Founder	623.65k	N/A	N/A
Mr. Saravan Subramaniam	Vice President of Operations & Supply Chain	N/A	N/A	N/A
Mr. Geoffrey Marr	Executive VP & General Counsel	N/A	N/A	N/A
Mr. Brett Moon	Vice President of Sales	N/A	N/A	N/A
Mr. Kirk Binns	Executive Vice President of Global Accounts	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Corporate Governance

MediPharm Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.